Stocks · Korea 052260 KOSDAQ

Hyundai Bioland

4,985원 -0.50% Market cap 1,496억 2026-10-07 close

📈 Chart & live quote

Data as of 2026-10-07 · Linked from 6 pages

An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER623.13x

PBR1.10x

EPS8 KRW

BPS4,538 KRW

ROE8.94%

Dividend yield1.40%

DPS70 KRW

Payout ratio875.00%

Returns and 52-week range

1W-12.70%

1M+25.16%

3M+39.83%

6M+17.86%

1Y+3.45%

YTD+14.19%

52W high6,240원

52W low3,125원

From 52W high-20.67%

Financial results (consolidated)

Period	Revenue	Operating income	Net income	OP margin
2022	992억	91억	48억	9.1%
2023	1,017억	71억	81억	7.0%
2024	1,195억	164억	57억	13.7%
2025	1,305억	127억	3억	9.7%
Quarterly
2024 4Q	215억	28억	-52억	12.9%
2025 1Q	337억	50억	-70억	14.8%
2025 2Q	346억	55억	51억	15.9%
2025 3Q	355억	47억	39억	13.3%
2025 4Q	267억	-25억	-18억	-9.3%
2026 1Q	382억	52억	52억	13.6%

Company

CEO이희준

Founded1995-09-01

Fiscal year end12

Websitewww.hyundaibioland.co.kr

Address: 충청북도 청주시 흥덕구 오송읍 오송생명2로 22 SK 바이오랜드 오송공장

Peers in the same sector

Company	Market cap	P/E	P/B	1M
켐트로스	1,503억	—	2.27	+23.61%
삼양패키징	1,484억	8.52	0.38	+0.10%
씨피시스템	1,543억	78.43	3.55	+5.22%
엘케이켐	1,473억	32.56	2.43	+16.95%
제이아이테크	1,546억	21.93	1.96	+36.27%
경인양행	1,432억	24.93	0.58	+8.86%

Recent filings

2026-08-14반기보고서 (2026.06)
2026-05-15분기보고서 (2026.03)

Source: DART (Financial Supervisory Service electronic disclosure)

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.